Related Experiment Video
Updated: May 7, 2026

Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
Inhibition of actin polymerization decreases osteogeneic differentiation of mesenchymal stem cells through p38 MAPK
Himangshu Sonowal1, Atul Kumar, Jina Bhattacharyya
1Stem Cell and Cancer Biology Group, Indian Institute of Technology Guwahati, Guwahati, Assam, India. bithiahgj@iitg.ernet.in.
Background:
Mesenchymal Stem Cells (MSC) are important candidates for therapeutic applications due to their ex vivo proliferation and differentiation capacity. MSC differentiation is controlled by both intrinsic and extrinsic factors and actin cytoskeleton plays a major role in the event. In the current study, we tried to understand the initial molecular mechanisms and pathways that regulate the differentiation of MSC into osteocytes or adipocytes.
Results:
We observed that actin modification was important during differentiation and differentially regulated during adipogenesis and osteogenesis. Initial disruption of actin polymerization reduced further differentiation of MSC into osteocytes and osteogenic differentiation was accompanied by increase in ERK1/2 and p38 MAPK phosphorylation. However, only p38 MAPK phosphorylation was down regulated upon inhibition of actin polymerization which as accompanied by decreased CD49E expression.
Conclusion:
Taken together, our results show that actin modification is a pre-requisite for MSC differentiation into osteocytes and adipocytes and osteogenic differentiation is regulated through p38 MAPK phosphorylation. Thus by modifying their cytoskeleton the differentiation potential of MSC could be controlled which might have important implications for tissue repair and regeneration.
Insights
Actin modification is crucial for mesenchymal stem cell (MSC) differentiation into bone or fat cells. Controlling the actin cytoskeleton may regulate MSC differentiation for tissue repair.
Area of Science:
- Cell Biology
- Biochemistry
- Regenerative Medicine
Background:
- Mesenchymal Stem Cells (MSCs) possess therapeutic potential due to their proliferation and differentiation capabilities.
- MSC differentiation is influenced by intrinsic and extrinsic factors, with the actin cytoskeleton playing a key role.
- Understanding the molecular mechanisms regulating MSC differentiation into osteocytes or adipocytes is crucial.
Purpose of the Study:
- To investigate the initial molecular mechanisms and pathways governing MSC differentiation into osteocytes and adipocytes.
- To elucidate the role of actin cytoskeleton modifications in MSC differentiation.
Main Methods:
- Studying actin polymerization and its impact on MSC differentiation.
- Analyzing the phosphorylation of ERK1/2 and p38 MAPK during osteogenic differentiation.
- Investigating the effect of actin polymerization inhibition on differentiation markers like CD49E expression.
Main Results:
- Actin modification is essential and differentially regulated during adipogenesis and osteogenesis.
- Disrupting actin polymerization initially hinders osteogenic differentiation.
- Osteogenic differentiation involves increased ERK1/2 and p38 MAPK phosphorylation, with p38 MAPK being downregulated upon actin polymerization inhibition, accompanied by decreased CD49E expression.
Conclusions:
- Actin modification is a prerequisite for MSC differentiation into osteocytes and adipocytes.
- Osteogenic differentiation is regulated via p38 MAPK phosphorylation.
- Modulating the MSC cytoskeleton offers potential for controlling differentiation in tissue repair and regeneration.
Related Concept Videos
Mesenchymal Stem Cells
TGF - β Signaling Pathway
